Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001551152-26-000008
Filing Date
2026-02-20
Accepted
2026-02-20 14:38:42
Documents
164
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K abbv-20251231.htm   iXBRL 10-K 3794601
2 EX-4.1 abbv-20251231xex41.htm EX-4.1 140876
3 EX-19 abbv-20251231xex19.htm EX-19 18113
4 EX-21 abbv-20251231xex21.htm EX-21 21383
5 EX-23 abbv-20251231xex23.htm EX-23 8542
6 EX-31.1 abbv-20251231xex311.htm EX-31.1 9370
7 EX-31.2 abbv-20251231xex312.htm EX-31.2 9397
8 EX-32.1 abbv-20251231xex321.htm EX-32.1 4861
9 EX-32.2 abbv-20251231xex322.htm EX-32.2 4755
15 abbv-20251231_g1.jpg GRAPHIC 15145
16 abbv-20251231_g2.gif GRAPHIC 748
17 abbv-20251231_g3.jpg GRAPHIC 119499
18 abbv-20251231xex19001.jpg GRAPHIC 174205
19 abbv-20251231xex19002.jpg GRAPHIC 230530
20 abbv-20251231xex19003.jpg GRAPHIC 206748
21 abbv-20251231xex19004.jpg GRAPHIC 205391
22 abbv-20251231xex19005.jpg GRAPHIC 228910
23 abbv-20251231xex19006.jpg GRAPHIC 161257
24 abbv-20251231xex21001.jpg GRAPHIC 81524
25 abbv-20251231xex21002.jpg GRAPHIC 75826
26 abbv-20251231xex21003.jpg GRAPHIC 77124
27 abbv-20251231xex21004.jpg GRAPHIC 71882
28 abbv-20251231xex21005.jpg GRAPHIC 78348
29 abbv-20251231xex21006.jpg GRAPHIC 67862
30 abbv-20251231xex21007.jpg GRAPHIC 77039
31 abbv-20251231xex21008.jpg GRAPHIC 74638
32 abbv-20251231xex21009.jpg GRAPHIC 68552
33 abbv-20251231xex21010.jpg GRAPHIC 72514
34 abbv-20251231xex21011.jpg GRAPHIC 73689
35 abbv-20251231xex21012.jpg GRAPHIC 23331
36 abbv-20251231xex21013.jpg GRAPHIC 69257
37 abbv-20251231xex21014.jpg GRAPHIC 76667
38 abbv-20251231xex21015.jpg GRAPHIC 79269
39 abbv-20251231xex21016.jpg GRAPHIC 78514
40 abbv-20251231xex21017.jpg GRAPHIC 70601
41 abbv-20251231xex21018.jpg GRAPHIC 85846
42 abbv-20251231xex21019.jpg GRAPHIC 80375
43 abbv-20251231xex21020.jpg GRAPHIC 82528
44 abbv-20251231xex21021.jpg GRAPHIC 79144
45 abbv-20251231xex21022.jpg GRAPHIC 66357
46 abbv-20251231xex21023.jpg GRAPHIC 79494
47 abbv-20251231xex21024.jpg GRAPHIC 78208
48 abbv-20251231xex21025.jpg GRAPHIC 78988
49 abbv-20251231xex21026.jpg GRAPHIC 71687
50 abbv-20251231xex21027.jpg GRAPHIC 75018
51 abbv-20251231xex21028.jpg GRAPHIC 77318
52 abbv-20251231xex21029.jpg GRAPHIC 81685
53 abbv-20251231xex21030.jpg GRAPHIC 29619
  Complete submission text file 0001551152-26-000008.txt   25373383

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20251231.xsd EX-101.SCH 114858
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abbv-20251231_cal.xml EX-101.CAL 191294
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20251231_def.xml EX-101.DEF 672592
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abbv-20251231_lab.xml EX-101.LAB 1460210
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20251231_pre.xml EX-101.PRE 1054317
167 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20251231_htm.xml XML 3944721
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35565 | Film No.: 26658769
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)